According to the results of recent tests carried out by independent laboratories in early 2021, Derprosa Antimicrobial films have proven to be effective against coronavirus SARS-CoV-2 (Covid-19) by inhibiting proliferation and neutralising bacteria and viruses’ survival on non-porous surfaces.
Derprosa Antimicrobial is the new designation of Derprosa™ Bacterstop films, which prevent infection by bacteria. The films have been tested against the Methicillin-resistant bacteria Staphylococcus Aureus (MRSA) and Escherichia Coli (E-Coli), the feline coronavirus (FCoV), and human coronavirus (SARS-CoV-2). Tests have shown that after 24 hours, there is a reduction of more than 84% of coronavirus SARS-CoV-2 on the film surface compared to a laminating film without the antimicrobial agent.
Derprosa Antimicrobial films, available in glossy and matte versions, are food contact approved (certified in Europe) and deliver a long-lasting antimicrobial effect that is odourless and totally safe. Moreover, they provide the same properties, machinability and technical performance as other traditional films.
This technology is also available across other Taghleef Industries’ film ranges designed for label applications and flexible packaging. It represents a cross-cutting and versatile solution suitable for multiple applications.
TAGHLEEF INDUSTRIES
https://www.ti-films.com/
